The U.K. is piloting a new genetic test developed by
Illumina Inc. (ILMN)
Illumina’s TruSight test, to be introduced in 2014 at the Royal Marsden hospitals in London and Sutton, can analyze 97 genes that are linked to cancer within a few weeks for a few ...
[Published BusinessWeek - May 20 2013]